Found 13 matching trials
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma PHASE1 This phase Ib/II trial studies the side effects and best dose of toll-like ...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
A Phase I/II Study of Intratumoral Injection of SD-101 PHASE1 This phase 1-2 trial studies the side effects and best dose of ipilimumab i...
Show More Location
Stanford University Hospitals and Clinics
Learn More & Join Trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer PHASE2 The purpose of this study is to further advance the ability to practice per...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection PHASE1 To determine safety, tolerability, and preliminary efficacy of escalating d...
Show More Location
Klinika Chorób Zakaźnych i Hepatologii Collegium Medicum Uniwersytet Mikołaja Kopernika
Learn More & Join Trial
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma PHASE1 To assess the safety and tolerability of escalating doses of SD-101 in comb...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma PHASE1 This study is an open-label, phase 1/1b study of the pressure-enabled intra...
Show More Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Learn More & Join Trial
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT PHASE2 This is a non-comparative open-label multicenter Phase 2 clinical trial com...
Show More Location
University of California San Francisco
Learn More & Join Trial
SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer PHASE1 This phase I trial studies the side effects of SD-101 when given together w...
Show More Location
University of California Davis Comprehensive Cancer Center
Learn More & Join Trial
Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors PHASE1 This is an Open-label, Phase 1b/2 Study of the Pressure-Enabled Hepatic Art...
Show More Location
University of Colorado
Learn More & Join Trial
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma PHASE1 This is a phase 1b/2, open-label, multicenter trial designed to evaluate th...
Show More Location
University of Alabama School of Medicine
Learn More & Join Trial